targeting the bclxl pathway in mpns
Published 1 year ago • 39 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:52
targeting the lectin pathway in hsct-tma
-
1:51
checkpoint inhibition in the treatment of mpns
-
3:13
targeting cd38 with a bispecific antibody to treat r/r aml: a phase i trial
-
8:31
targeting bcl-2 in mds
-
2:17
insights into the real-world efficacy of luspatercept in patients with lr-mds
-
1:46:07
hematology lecture
-
46:21
diapath - webinar - quality control in immunohistochemistry
-
28:08
dr. gaby hobbs, md: diagnosis and initial treatment options for et, pv & mf
-
4:16
novel therapies for mpns
-
2:36
a cd38-targeting bispecific antibody in the treatment of r/r t-all
-
1:01
the importance of targeting other pathways after jaki treatment failure
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:27
advances in btk and bcl2 inhibitors for cll
-
2:41
an overview of the latest advances in hematology
-
1:41
updates on ropeginterferon in mpns
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
26:22
key takeaways in mpns
-
5:04
efficacy and safety of m-pola for r/r b-cell nhl
-
10:01
novel targets in 2022
-
8:57
outcomes of sct in t-all and t-lbl
-
2:13
splicing mutations in post-et/post-pv myelofibrosis
-
1:24
sequencing of btk inhibitors in cll